Finance

Chart Of The Day – Dentsply International (XRAY)

  The Chart of the Day belongs to Dentsply International (XRAY).  I found the stock by sorting the All Time High list for the stocks hitting the most frequent new highs in the last month then used the Flipchart feature to review the charts.  Since the Trend Spotter signaled a buy on 10/27 the stock gained 19.07%. Dentsply International Inc. designs, develops, manufactures…

Broad Selling

Bears paid an early visit to Santa with a broad selling. The relative loss was minor, although volume climbed to register to confirmed distribution. The Nasdaq delivered on the ‘bear flag’ breakdown, which will give shorts something to work with.  The index finished on its 20-day MA. but this hasn’t played as support in recent…

EC This Time I

We are now far advanced into the third central bank generated bubble of the last two decades, but our monetary politburo has taken no notice whatsoever of its self-evident leading wave. Namely, the massive malinvestments and debt mania in the shale patch. Call them monetary Bourbons. It is no exaggeration to say that inhabitants of the…

Betting On The ‘Other’ Oil Black Swan

With oil prices plunging to 5-year lows, perhaps it is time to consider the cheapness of betting on the other oil black swan… Via BofA’s Jake Greenberg, In my base case, I remain structurally bearish oil.  The world is making huge productivity and efficiency gains (lighter vehicles, new technology, etc.), and we are starting to…

E

Shares of Cubist Pharmaceuticals (CBST) rose as much as 35% after Merck (MRK) announced that it would acquire the company for approximately $9.5 billion. This translates to Merck paying $102 per share for Cubist while also covering $1.1B in debt, and will allow Merck to acquire a new set of antibacterial drugs. The deal makes…

Symmetry Medical Divests OEM, Surgical Goes Public

Symmetry Medical Inc. (until recently SMA) recently completed the divestiture of its OEM solutions business unit to Tecomet Inc. The deal, announced in Aug 2014, was valued at $450 million in cash after fees and elimination of outstanding debt. Symmetry Medical also completed the transfer of the remaining surgical business to a new company called…